Hvivo (HVO) RNS Announcements

Add to Alert list
Date Time Source Announcement
19 Dec 2022 07:00 AM
RNS
Imutex Phase I data published
17 Nov 2022 02:05 PM
RNS
Second Price Monitoring Extn
17 Nov 2022 02:00 PM
RNS
Price Monitoring Extension
14 Nov 2022 11:14 AM
EQS
hVIVO hails growing contract values after winni...
11 Nov 2022 07:00 AM
RNS
Exercise of Options
10 Nov 2022 11:00 AM
RNS
Price Monitoring Extension
10 Nov 2022 08:22 AM
RNS
£13.6m RSV antiviral contract
04 Nov 2022 07:25 AM
RNS
Holding(s) in Company
25 Oct 2022 07:00 AM
RNS
Change of name to hVIVO plc effective
20 Oct 2022 07:00 AM
RNS
Capital Markets Day
18 Oct 2022 07:00 AM
RNS
CFO appointment & change of Board roles
30 Sep 2022 07:00 AM
RNS
Positive in vitro results for FLU-v published
29 Sep 2022 09:30 AM
RNS
Director dealings
27 Sep 2022 07:00 AM
RNS
Upcoming Scientific Presentations
15 Sep 2022 07:00 AM
RNS
Comment regarding press speculation
08 Sep 2022 07:01 AM
RNS
Interim results and trading update
08 Sep 2022 07:00 AM
RNS
Intention to change name to hVIVO plc
01 Sep 2022 07:20 AM
RNS
CAP accreditation
25 Aug 2022 07:00 AM
RNS
Notice of results
22 Aug 2022 07:00 AM
RNS
£10.4m contract with existing Big Pharma client
04 Aug 2022 07:00 AM
RNS
£6.2m Influenza human challenge study contract
05 Jul 2022 01:17 PM
RNS
Result of AGM
30 Jun 2022 07:00 AM
RNS
Omicron human challenge model
14 Jun 2022 07:00 AM
RNS
£7.2m RSV human challenge study contract
10 Jun 2022 12:13 PM
RNS
Board appointment amendment
10 Jun 2022 12:00 PM
RNS
Annual Report and Notice of AGM
08 Jun 2022 07:00 AM
RNS
Board appointment
07 Jun 2022 09:05 AM
RNS
Second Price Monitoring Extn
07 Jun 2022 09:00 AM
RNS
Price Monitoring Extension
07 Jun 2022 07:00 AM
RNS
Final results
01 Jun 2022 07:00 AM
RNS
GBP14.7m influenza contract signed
26 May 2022 07:00 AM
RNS
Completion of Nominated Adviser due diligence
24 May 2022 07:00 AM
RNS
Notice of results
18 May 2022 07:00 AM
RNS
£7.3m Influenza human challenge study contract win
12 May 2022 07:00 AM
RNS
Wellcome publication
05 May 2022 07:00 AM
RNS
Vaccine field study contract
04 May 2022 07:00 AM
RNS
Challenge virus manufacturing contract
04 May 2022 07:00 AM
RNS
Comment re: speculation
28 Apr 2022 07:00 AM
RNS
Appointment of Nominated Adviser and Joint Broker
13 Apr 2022 07:00 AM
RNS
Proposal to Distribution in Specie Shareholders
12 Apr 2022 12:00 PM
RNS
Presentation at World Vaccine Congress
06 Apr 2022 04:35 PM
RNS
Price Monitoring Extension
06 Apr 2022 02:05 PM
RNS
Second Price Monitoring Extn
06 Apr 2022 02:01 PM
RNS
Price Monitoring Extension
06 Apr 2022 11:05 AM
RNS
Second Price Monitoring Extn
06 Apr 2022 11:00 AM
RNS
Price Monitoring Extension
31 Mar 2022 10:05 AM
RNS
Characterisation Study results in Nature Medicine
25 Mar 2022 07:00 AM
RNS
£5m RSV human challenge study contract win
09 Mar 2022 04:41 PM
RNS
Second Price Monitoring Extn
09 Mar 2022 04:37 PM
RNS
Price Monitoring Extension
UK 100